PARCA (a digital tool) to improve Justice and Health

PARCA(数字工具)改善司法和健康

基本信息

  • 批准号:
    10483296
  • 负责人:
  • 金额:
    $ 25.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-05-01 至 2024-04-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT Nearly 4.4 million individuals are on community supervision in the United States, with the majority (about 80%) being supervised under probation.1 Justice involved persons (JIPs) have a 474% increased lifetime experience with heroin, a 303% increased use of OxyContin in the last 12 months, and a 256% increased use in pain medication in the last 12 months, compared to the general population.3 One important step in addressing substance use and addiction is getting individuals engaged in the treatment process, as initiation and retention rates are very low for substance use treatment among this population. Q2i successfully developed the Probation/Parole And Reentry Coach Application (PARCA) technology, which includes a Justice Team (JT) Dashboard connected to a mobile app designed for JIPs. The platform enables JIPs to set and manage their personal goals while assisting them in addressing the social determinants of health (SDOH) in order to facilitate and supplement the substance use treatment process. It provides a step-by-step guide and identifies local services and resources that the JIPs can connect with to accomplish these goals. At the same time, it gives the JT a dashboard that enables greater insight on how a JIP is managing their plan. This increased connection and communication between the JT and the JIP is designed to improve the community supervision process. In this Phase 1/Phase 2 Fast Track STTR application, Q2i’s PARCA platform will be refined and implemented in Dallas and Hidalgo Counties to test its efficacy. The primary goal of Phase I is to enhance the PARCA platform for JIP. The study team will accomplish this by recruiting three sets of 2 PPOs/Case Managers willing to use PARCA with five of their clients who have used any opioids in the last 12 months (total JIPs = 30) for 2- weeks. The team will conduct interviews with PPOs and their clients that will inform our user-centered design iterations. Initial interviews will describe barriers and challenges to successful community supervision including accessing MOUD treatment and how PARCA can be improved to address these challenges. Follow- up interviews will describe feasibility (use of the PARCA platform features) and acceptability (engagement with PARCA platform through user engagement logs) of using PARCA platform to locate and access MOUD treatment. The overall goal of Phase II is to test the relative efficacy of supervision as usual (SAU) and PARCA in helping JIPs under community supervision engage in substance use treatment process and reduce subsequent involvement in criminal behavior. Using a stepped wedge effectiveness design, we will evaluate the PARCA platform across probation/parole officers (PPOs) (N=60), probationers/parolees (N=600). PPOs will be randomized in three clusters of 20 people to utilize PARCA. Lastly, we will assess the acceptability and feasibility of PARCA platform by supervision officers and justice-involved persons (JIPs) and whether PARCA improves the working alliance between supervisors and JIPs.
项目总结/摘要 在美国,近440万人接受社区监督,其中大多数(约 司法参与者(JIP)的寿命增加了474% 海洛因的使用经验,在过去12个月内奥施康定的使用增加了303%, 与一般人群相比,在过去12个月内使用止痛药的人数。 物质使用和成瘾是让个人参与治疗过程,作为启动和保留 在这一人群中,接受药物使用治疗的比例非常低。Q2 i成功开发了 缓刑/假释和重返社会教练应用(PARCA)技术,其中包括一个司法团队(JT) 仪表板连接到专为JIP设计的移动的应用程序。该平台使JIP能够设置和管理其 个人目标,同时帮助他们解决健康的社会决定因素, 促进和补充物质使用处理过程。它提供了一个分步指南,并确定了 JIP可以连接以实现这些目标的本地服务和资源。与此同时, JT是一个仪表板,可以更深入地了解JIP如何管理他们的计划。这种增加的联系 JT和JIP之间的沟通旨在改善社区监督过程。在 在第一阶段/第二阶段的快速通道STTR应用中,Q2 i的PARCA平台将在 达拉斯和伊达尔戈县测试其功效。第一阶段的主要目标是加强PARCA JIP平台研究团队将通过招募三组(每组2名)愿意 在过去12个月内使用任何阿片类药物的5名客户(JIP总数= 30)中使用PARCA 2- 周该团队将与PPO及其客户进行访谈,以告知我们以用户为中心的设计 迭代。最初的访谈将描述成功的社区监督的障碍和挑战 包括获得MOUD治疗以及如何改进PARCA以应对这些挑战。关注- 向上访谈将描述可行性(PARCA平台功能的使用)和可接受性(参与 使用PARCA平台定位和访问MOUD 治疗第二阶段的总体目标是测试常规监管的相对功效, PARCA帮助社区监督下的JIP参与物质使用治疗过程, 随后参与犯罪行为。使用阶梯楔有效性设计,我们将评估 PARCA平台跨缓刑/假释官(PPO)(N=60),缓刑犯/假释犯(N=600)。PPO将 随机分为三组,每组20人,使用PARCA。最后,我们将评估可接受性, 监管人员和司法参与者(JIPs)是否可以使用PARCA平台,以及 PARCA改善了主管和JIP之间的工作联盟。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Faye S Taxman其他文献

The cost-effectiveness of implementing in-person and computerized interventions to enhance treatment receipt among drug-involved probationers in two US jurisdictions (Economics of SBI Symposium)
  • DOI:
    10.1186/1940-0640-10-s2-o13
  • 发表时间:
    2015-09-24
  • 期刊:
  • 影响因子:
    3.200
  • 作者:
    Alexander Cowell;Gary A Zarkin;Brendan Wedehase;Scott T Walters;Faye S Taxman
  • 通讯作者:
    Faye S Taxman
Feasibility of a pretrial diversion pilot in Kent County, Rhode Island
  • DOI:
    10.1186/1940-0640-10-s1-a68
  • 发表时间:
    2015-02-20
  • 期刊:
  • 影响因子:
    3.200
  • 作者:
    Anna F Tomasulo;Nickolas Zaller;Bradley W Brockmann;Jennifer Lerch;Scott T Walters;Faye S Taxman
  • 通讯作者:
    Faye S Taxman
Client involvement in motivational interviewing sessions targeting substance abuse treatment in the criminal justice system
  • DOI:
    10.1186/1940-0640-10-s1-a67
  • 发表时间:
    2015-02-20
  • 期刊:
  • 影响因子:
    3.200
  • 作者:
    Teneshia Thurman;Faye S Taxman;Scott T Walters
  • 通讯作者:
    Scott T Walters
Geographic accessibility to addiction, mental health, and HIV/AIDS health-care services for opioid-dependent clients
  • DOI:
    10.1186/1940-0640-10-s1-a10
  • 发表时间:
    2015-02-20
  • 期刊:
  • 影响因子:
    3.200
  • 作者:
    Curtis J Denton;Debarchana Ghosh;Faye S Taxman;Frederick L Altice
  • 通讯作者:
    Frederick L Altice
Client involvement in a web-based intervention targeting substance abuse treatment in the criminal justice system
  • DOI:
    10.1186/1940-0640-10-s1-a61
  • 发表时间:
    2015-02-20
  • 期刊:
  • 影响因子:
    3.200
  • 作者:
    Stephanie Spohr;Mayra Rodriguez;Jennifer Lerch;Faye S Taxman;Scott T Walters
  • 通讯作者:
    Scott T Walters

Faye S Taxman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Faye S Taxman', 18)}}的其他基金

HEAL Accelerator: Leveraging Partnerships and Targeted Dissemination to Advance Uptake
HEAL 加速器:利用合作伙伴关系和有针对性的传播来促进吸收
  • 批准号:
    10667038
  • 财政年份:
    2022
  • 资助金额:
    $ 25.6万
  • 项目类别:
HEAL Accelerator: Leveraging Partnerships and Targeted Dissemination to Advance Uptake
HEAL 加速器:利用合作伙伴关系和有针对性的传播来促进吸收
  • 批准号:
    10915749
  • 财政年份:
    2022
  • 资助金额:
    $ 25.6万
  • 项目类别:
Implementation and Translation Research Project Core
实施和翻译研究项目核心
  • 批准号:
    10219226
  • 财政年份:
    2019
  • 资助金额:
    $ 25.6万
  • 项目类别:
Implementation and Translation Research Project Core
实施和翻译研究项目核心
  • 批准号:
    10696068
  • 财政年份:
    2019
  • 资助金额:
    $ 25.6万
  • 项目类别:
Admin - Core
管理员 - 核心
  • 批准号:
    10219223
  • 财政年份:
    2019
  • 资助金额:
    $ 25.6万
  • 项目类别:
In-person vs. Computer Interventions to Increase Probation Compliance
面对面与计算机干预以提高缓刑合规性
  • 批准号:
    8607919
  • 财政年份:
    2011
  • 资助金额:
    $ 25.6万
  • 项目类别:
In-person vs. Computer Interventions to Increase Probation Compliance
面对面与计算机干预以提高缓刑合规性
  • 批准号:
    8665758
  • 财政年份:
    2011
  • 资助金额:
    $ 25.6万
  • 项目类别:
In-person vs. Computer Interventions to Increase Probation Compliance
面对面与计算机干预以提高缓刑合规性
  • 批准号:
    8661519
  • 财政年份:
    2011
  • 资助金额:
    $ 25.6万
  • 项目类别:
In-person vs. Computer Interventions to Increase Probation Compliance
面对面与计算机干预以提高缓刑合规性
  • 批准号:
    8236911
  • 财政年份:
    2011
  • 资助金额:
    $ 25.6万
  • 项目类别:
In-person vs. Computer Interventions to Increase Probation Compliance
面对面与计算机干预以提高缓刑合规性
  • 批准号:
    8304729
  • 财政年份:
    2011
  • 资助金额:
    $ 25.6万
  • 项目类别:

相似海外基金

Planning Study for the Development of Sigma 2 ligands as Analgesics
Sigma 2 配体镇痛药开发规划研究
  • 批准号:
    10641500
  • 财政年份:
    2023
  • 资助金额:
    $ 25.6万
  • 项目类别:
Designing and validating optimal nonaddictive analgesics using the CANDO paradigm
使用 CANDO 范式设计和验证最佳的非成瘾性镇痛药
  • 批准号:
    10485593
  • 财政年份:
    2023
  • 资助金额:
    $ 25.6万
  • 项目类别:
Identification of botanical hHv1 channel blockers as analgesics for neuropathic pain
植物 hHv1 通道阻滞剂作为神经性疼痛镇痛药的鉴定
  • 批准号:
    10728526
  • 财政年份:
    2023
  • 资助金额:
    $ 25.6万
  • 项目类别:
Development of LPA5 Antagonists as Analgesics
LPA5 拮抗剂镇痛药的开发
  • 批准号:
    10638278
  • 财政年份:
    2023
  • 资助金额:
    $ 25.6万
  • 项目类别:
Designed Multiple Ligands as Non-opioid Analgesics for Treating Chronic Pain
设计多种配体作为非阿片类镇痛药,用于治疗慢性疼痛
  • 批准号:
    10621646
  • 财政年份:
    2023
  • 资助金额:
    $ 25.6万
  • 项目类别:
Elucidation of the mechanism of pain suppression by exercise and development of new analgesics
阐明运动镇痛机制及开发新型镇痛药
  • 批准号:
    22K19602
  • 财政年份:
    2022
  • 资助金额:
    $ 25.6万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
  • 批准号:
    10425794
  • 财政年份:
    2022
  • 资助金额:
    $ 25.6万
  • 项目类别:
Allosteric Targeting of Cannabinoid CB1 Receptor to Develop Non-Addictive Small Molecule Analgesics
大麻素 CB1 受体变构靶向开发非成瘾性小分子镇痛药
  • 批准号:
    10512672
  • 财政年份:
    2022
  • 资助金额:
    $ 25.6万
  • 项目类别:
A novel clinically-relevant mouse model of chronic overlapping pain conditions for screening analgesics
用于筛选镇痛药的新型临床相关慢性重叠疼痛小鼠模型
  • 批准号:
    10821681
  • 财政年份:
    2022
  • 资助金额:
    $ 25.6万
  • 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
  • 批准号:
    10721752
  • 财政年份:
    2022
  • 资助金额:
    $ 25.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了